ArticleJournal for immunotherapy of cancer2024

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.

Rodabe Amaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.